This analysis provides the first evidence of the applicability of the revised IWG-ELN criteria in the setting of RUX-treated MF patients outside of clinical trials.
The 2024 Three-Strata Baseline Anemia Definition of the Revised IWG-ELN Criteria Dissects Survival in Ruxolitinib-Treated Myelofibrosis Patients
Rumi, E;
2025-01-01
Abstract
This analysis provides the first evidence of the applicability of the revised IWG-ELN criteria in the setting of RUX-treated MF patients outside of clinical trials.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
